237 related articles for article (PubMed ID: 11490743)
1. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
[TBL] [Abstract][Full Text] [Related]
2. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation.
Lau CH; Comer M; Lightman S
Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
7. Monitoring trough plasma concentrations of mycophenolate mofetil in patients with uveitis.
Llinares-Tello F; Hernández-Prats C; Muñoz-Ruiz C; Selva-Otaolaurruchi J; Ordovás-Baines JP
J Clin Pharm Ther; 2004 Feb; 29(1):53-8. PubMed ID: 14748898
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of uveitis.
Teoh SC; Hogan AC; Dick AD; Lee RW
Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
[TBL] [Abstract][Full Text] [Related]
9. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil monotherapy in the management of paediatric uveitis.
Chang PY; Giuliari GP; Shaikh M; Thakuria P; Makhoul D; Foster CS
Eye (Lond); 2011 Apr; 25(4):427-35. PubMed ID: 21423146
[TBL] [Abstract][Full Text] [Related]
11. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
12. [Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study].
Reinhard T; Reis A; Kutkuhn B; Voiculescu A; Sundmacher R
Klin Monbl Augenheilkd; 1999 Sep; 215(3):201-2. PubMed ID: 10528287
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil in the therapy of uveitic macular edema--long-term results.
Doycheva D; Zierhut M; Blumenstock G; Stuebiger N; Deuter C
Ocul Immunol Inflamm; 2012 Jun; 20(3):203-11. PubMed ID: 22489750
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis.
Rathinam SR; Babu M; Thundikandy R; Kanakath A; Nardone N; Esterberg E; Lee SM; Enanoria WT; Porco TC; Browne EN; Weinrib R; Acharya NR
Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
Bagga A; Hari P; Moudgil A; Jordan SC
Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease.
Cuchacovich M; Solanes F; Perez C; Verdaguer JI; Verdaguer J; Castiglione E; Carpentier C; Traipe L; Villarroel F
J Ocul Pharmacol Ther; 2016; 32(1):55-61. PubMed ID: 26562247
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil for ocular inflammation.
Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
[TBL] [Abstract][Full Text] [Related]
20. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.
Tedoriya T; Keogh AM; Kusano K; Savdie E; Hayward C; Spratt PM; Wilson M; Macdonald PS
J Heart Lung Transplant; 2002 Sep; 21(9):976-82. PubMed ID: 12231368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]